LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting (AGM) on Tuesday, June 3, 2025, at 10:00 am CET.
While Materialise's Q1 results were mixed they exceeded low investor expectations, with the company's Medical segment continuing to excel. Market conditions are likely to remain challenging, but lower energy costs and increased defense spending in Europe could help to offset this. Materialise's Medical segment alone more than justifies its current market capitalization.
Materialise NV (NASDAQ:MTLS ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Harriet Fried - Alliance Advisors, IR Brigitte de Vet - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Operator Good day and thank you for standing by. Welcome to the First Quarter 2025 Materialise Financial Results Conference Call.
24 Oct 2024 Date | | - Cons. EPS | - EPS |
24 Jul 2024 Date | | - Cons. EPS | - EPS |
25 Apr 2024 Date | | - Cons. EPS | - EPS |
21 Feb 2024 Date | | - Cons. EPS | - EPS |
12 Feb 2024 Date | | - Cons. EPS | - EPS |
24 Oct 2024 Date | | - Cons. EPS | - EPS |
24 Jul 2024 Date | | - Cons. EPS | - EPS |
25 Apr 2024 Date | | - Cons. EPS | - EPS |
21 Feb 2024 Date | | - Cons. EPS | - EPS |
12 Feb 2024 Date | | - Cons. EPS | - EPS |
Software - Application Industry | Technology Sector | Ms. Brigitte de Vet-Veithen CEO | XSTU Exchange | US57667T1007 ISIN |
BE Country | 488 Employees | - Last Dividend | - Last Split | 25 Jun 2014 IPO Date |
Materialise NV stands as a pivotal provider in the realms of additive manufacturing and medical software, coupled with 3D printing services, which spans across the Americas, Europe and Africa, and the Asia-Pacific. With its operational foundation laid down in 1990 and headquartered in Leuven, Belgium, Materialise NV has compartmentalized its expertise into three primary segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The company has fostered collaborative agreements with eminent entities like Zimmer Biomet Holdings, Inc., Encore Medical, L.P., DePuy Synthes Companies of Johnson & Johnson, and several others, demonstrating its industry significance and widespread trust. This extensive collaboration network underscores Materialise NV's influential role in advancing 3D printing applications within both industrial and medical frameworks.
Facilitates and enhances 3D printing operations through a comprehensive suite of software programs and platforms. This segment bridges various 3D printers with numerous software applications and capturing technologies, including CAD/CAM packages and 3D scanners. Its target clientele encompasses 3D printing machine manufacturers, production companies, and contract manufacturers across industries such as automotive, aerospace, consumer goods, and hearing aids, in addition to 3D printing service bureaus. Distribution is achieved via a direct sales force, a dedicated website, and through third-party resellers.
Focuses on delivering medical software that facilitates the analysis, planning, and engineering based on medical imaging, as well as the patient-specific design and printing of surgical devices and implants. This segment's offerings are primarily directed at medical device companies, hospitals, universities, research institutes, and industrial entities. Distribution is steered through direct sales efforts, the company's website, and Picture Archiving Communication Systems (PACS), underscoring Materialise's pivotal role in innovating medical procedures and patient care.
Provides 3D printing services alongside design and engineering services, catering to the rapid prototyping and additive manufacturing needs of production parts for industrial and commercial clients. This segment encapsulates Materialise NV's direct contribution to the manufacturing industry, showcasing its capabilities in turning conceptual designs into tangible, high-quality parts and products through state-of-the-art 3D printing technologies.